[(2S)-1-[[(2S)-1-[4-[(6aS)-3-[5-[[(6aS)-2-methoxy-8-[4-(4-methylpiperazin-1-yl)phenyl]-11-oxo-6a,7-dihydropyrrolo[2,1-c][1,4]benzodiazepin-3-yl]oxy]pentoxy]-2-methoxy-11-oxo-6a,7-dihydropyrrolo[2,1-c][1,4]benzodiazepin-8-yl]anilino]-1-oxopropan-2-yl]amino]-3-methyl-1-oxobutan-2-yl]-(9H-fluoren-9-ylmethyl)carbamic acid

C71H75N9O10 — CID 122506113

IUPAC[(2S)-1-[[(2S)-1-[4-[(6aS)-3-[5-[[(6aS)-2-methoxy-8-[4-(4-methylpiperazin-1-yl)phenyl]-11-oxo-6a,7-dihydropyrrolo[2,1-c][1,4]benzodiazepin-3-yl]oxy]pentoxy]-2-methoxy-11-oxo-6a,7-dihydropyrrolo[2,1-c][1,4]benzodiazepin-8-yl]anilino]-1-oxopropan-2-yl]amino]-3-methyl-1-oxobutan-2-yl]-(9H-fluoren-9-ylmethyl)carbamic acid
SMILESCOc1cc2c(cc1OCCCCCOc1cc3c(cc1OC)C(=O)N1C=C(c4ccc(N5CCN(C)CC5)cc4)C[C@H]1C=N3)N=C[C@@H]1CC(c3ccc(NC(=O)[C@H](C)NC(=O)[C@H](C(C)C)N(CC4c5ccccc5-c5ccccc54)C(=O)O)cc3)=CN1C2=O
InChIInChI=1S/C71H75N9O10/c1-43(2)66(80(71(85)86)42-59-55-16-10-8-14-53(55)54-15-9-11-17-56(54)59)68(82)74-44(3)67(81)75-49-22-18-45(19-23-49)47-32-51-38-72-60-36-64(62(87-5)34-57(60)69(83)78(51)40-47)89-30-12-7-13-31-90-65-37-61-58(35-63(65)88-6)70(84)79-41-48(33-52(79)39-73-61)46-20-24-50(25-21-46)77-28-26-76(4)27-29-77/h8-11,14-25,34-41,43-44,51-52,59,66H,7,12-13,26-33,42H2,1-6H3,(H,74,82)(H,75,81)(H,85,86)/t44-,51-,52-,66-/m0/s1
InChIKeyJGWFMPLTSGIRNV-PPZHCWCGSA-N
MW1214.43 g/mol
LogP11.29
Rot. Bonds21

About [(2S)-1-[[(2S)-1-[4-[(6aS)-3-[5-[[(6aS)-2-methoxy-8-[4-(4-methylpiperazin-1-yl)phenyl]-11-oxo-6a,7-dihydropyrrolo[2,1-c][1,4]benzodiazepin-3-yl]oxy]pentoxy]-2-methoxy-11-oxo-6a,7-dihydropyrrolo[2,1-c][1,4]benzodiazepin-8-yl]anilino]-1-oxopropan-2-yl]amino]-3-methyl-1-oxobutan-2-yl]-(9H-fluoren-9-ylmethyl)carbamic acid

[(2S)-1-[[(2S)-1-[4-[(6aS)-3-[5-[[(6aS)-2-methoxy-8-[4-(4-methylpiperazin-1-yl)phenyl]-11-oxo-6a,7-dihydropyrrolo[2,1-c][1,4]benzodiazepin-3-yl]oxy]pentoxy]-2-methoxy-11-oxo-6a,7-dihydropyrrolo[2,1-c][1,4]benzodiazepin-8-yl]anilino]-1-oxopropan-2-yl]amino]-3-methyl-1-oxobutan-2-yl]-(9H-fluoren-9-ylmethyl)carbamic acid (PubChem CID 122506113) has the molecular formula C71H75N9O10 and a molecular weight of 1214.43 g/mol. Its IUPAC name is [(2S)-1-[[(2S)-1-[4-[(6aS)-3-[5-[[(6aS)-2-methoxy-8-[4-(4-methylpiperazin-1-yl)phenyl]-11-oxo-6a,7-dihydropyrrolo[2,1-c][1,4]benzodiazepin-3-yl]oxy]pentoxy]-2-methoxy-11-oxo-6a,7-dihydropyrrolo[2,1-c][1,4]benzodiazepin-8-yl]anilino]-1-oxopropan-2-yl]amino]-3-methyl-1-oxobutan-2-yl]-(9H-fluoren-9-ylmethyl)carbamic acid.

Molecular Properties

Compound Name[(2S)-1-[[(2S)-1-[4-[(6aS)-3-[5-[[(6aS)-2-methoxy-8-[4-(4-methylpiperazin-1-yl)phenyl]-11-oxo-6a,7-dihydropyrrolo[2,1-c][1,4]benzodiazepin-3-yl]oxy]pentoxy]-2-methoxy-11-oxo-6a,7-dihydropyrrolo[2,1-c][1,4]benzodiazepin-8-yl]anilino]-1-oxopropan-2-yl]amino]-3-methyl-1-oxobutan-2-yl]-(9H-fluoren-9-ylmethyl)carbamic acid
PubChem CID122506113
Molecular FormulaC71H75N9O10
Molecular Weight1214.43 g/mol
Exact Mass1213.56
IUPAC Name[(2S)-1-[[(2S)-1-[4-[(6aS)-3-[5-[[(6aS)-2-methoxy-8-[4-(4-methylpiperazin-1-yl)phenyl]-11-oxo-6a,7-dihydropyrrolo[2,1-c][1,4]benzodiazepin-3-yl]oxy]pentoxy]-2-methoxy-11-oxo-6a,7-dihydropyrrolo[2,1-c][1,4]benzodiazepin-8-yl]anilino]-1-oxopropan-2-yl]amino]-3-methyl-1-oxobutan-2-yl]-(9H-fluoren-9-ylmethyl)carbamic acid
SMILESCOc1cc2c(cc1OCCCCCOc1cc3c(cc1OC)C(=O)N1C=C(c4ccc(N5CCN(C)CC5)cc4)C[C@H]1C=N3)N=C[C@@H]1CC(c3ccc(NC(=O)[C@H](C)NC(=O)[C@H](C(C)C)N(CC4c5ccccc5-c5ccccc54)C(=O)O)cc3)=CN1C2=O
InChIInChI=1S/C71H75N9O10/c1-43(2)66(80(71(85)86)42-59-55-16-10-8-14-53(55)54-15-9-11-17-56(54)59)68(82)74-44(3)67(81)75-49-22-18-45(19-23-49)47-32-51-38-72-60-36-64(62(87-5)34-57(60)69(83)78(51)40-47)89-30-12-7-13-31-90-65-37-61-58(35-63(65)88-6)70(84)79-41-48(33-52(79)39-73-61)46-20-24-50(25-21-46)77-28-26-76(4)27-29-77/h8-11,14-25,34-41,43-44,51-52,59,66H,7,12-13,26-33,42H2,1-6H3,(H,74,82)(H,75,81)(H,85,86)/t44-,51-,52-,66-/m0/s1
InChIKeyJGWFMPLTSGIRNV-PPZHCWCGSA-N
XLogP11.29
TPSA207.48 Ų
H-Bond Donors3
H-Bond Acceptors13
Rotatable Bonds21
Heavy Atoms90
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5001214.43
LogP ≤ 511.29
H-Bond Donors ≤ 53
H-Bond Acceptors ≤ 1013

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'anil_di_alk_B(251)', 'substructure': 'N/A'}, {'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}

Analyze [(2S)-1-[[(2S)-1-[4-[(6aS)-3-[5-[[(6aS)-2-methoxy-8-[4-(4-methylpiperazin-1-yl)phenyl]-11-oxo-6a,7-dihydropyrrolo[2,1-c][1,4]benzodiazepin-3-yl]oxy]pentoxy]-2-methoxy-11-oxo-6a,7-dihydropyrrolo[2,1-c][1,4]benzodiazepin-8-yl]anilino]-1-oxopropan-2-yl]amino]-3-methyl-1-oxobutan-2-yl]-(9H-fluoren-9-ylmethyl)carbamic acid with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of [(2S)-1-[[(2S)-1-[4-[(6aS)-3-[5-[[(6aS)-2-methoxy-8-[4-(4-methylpiperazin-1-yl)phenyl]-11-oxo-6a,7-dihydropyrrolo[2,1-c][1,4]benzodiazepin-3-yl]oxy]pentoxy]-2-methoxy-11-oxo-6a,7-dihydropyrrolo[2,1-c][1,4]benzodiazepin-8-yl]anilino]-1-oxopropan-2-yl]amino]-3-methyl-1-oxobutan-2-yl]-(9H-fluoren-9-ylmethyl)carbamic acid?
The IUPAC name of [(2S)-1-[[(2S)-1-[4-[(6aS)-3-[5-[[(6aS)-2-methoxy-8-[4-(4-methylpiperazin-1-yl)phenyl]-11-oxo-6a,7-dihydropyrrolo[2,1-c][1,4]benzodiazepin-3-yl]oxy]pentoxy]-2-methoxy-11-oxo-6a,7-dihydropyrrolo[2,1-c][1,4]benzodiazepin-8-yl]anilino]-1-oxopropan-2-yl]amino]-3-methyl-1-oxobutan-2-yl]-(9H-fluoren-9-ylmethyl)carbamic acid (CID 122506113) is [(2S)-1-[[(2S)-1-[4-[(6aS)-3-[5-[[(6aS)-2-methoxy-8-[4-(4-methylpiperazin-1-yl)phenyl]-11-oxo-6a,7-dihydropyrrolo[2,1-c][1,4]benzodiazepin-3-yl]oxy]pentoxy]-2-methoxy-11-oxo-6a,7-dihydropyrrolo[2,1-c][1,4]benzodiazepin-8-yl]anilino]-1-oxopropan-2-yl]amino]-3-methyl-1-oxobutan-2-yl]-(9H-fluoren-9-ylmethyl)carbamic acid.
What is the SMILES notation for [(2S)-1-[[(2S)-1-[4-[(6aS)-3-[5-[[(6aS)-2-methoxy-8-[4-(4-methylpiperazin-1-yl)phenyl]-11-oxo-6a,7-dihydropyrrolo[2,1-c][1,4]benzodiazepin-3-yl]oxy]pentoxy]-2-methoxy-11-oxo-6a,7-dihydropyrrolo[2,1-c][1,4]benzodiazepin-8-yl]anilino]-1-oxopropan-2-yl]amino]-3-methyl-1-oxobutan-2-yl]-(9H-fluoren-9-ylmethyl)carbamic acid?
The canonical SMILES for [(2S)-1-[[(2S)-1-[4-[(6aS)-3-[5-[[(6aS)-2-methoxy-8-[4-(4-methylpiperazin-1-yl)phenyl]-11-oxo-6a,7-dihydropyrrolo[2,1-c][1,4]benzodiazepin-3-yl]oxy]pentoxy]-2-methoxy-11-oxo-6a,7-dihydropyrrolo[2,1-c][1,4]benzodiazepin-8-yl]anilino]-1-oxopropan-2-yl]amino]-3-methyl-1-oxobutan-2-yl]-(9H-fluoren-9-ylmethyl)carbamic acid is COc1cc2c(cc1OCCCCCOc1cc3c(cc1OC)C(=O)N1C=C(c4ccc(N5CCN(C)CC5)cc4)C[C@H]1C=N3)N=C[C@@H]1CC(c3ccc(NC(=O)[C@H](C)NC(=O)[C@H](C(C)C)N(CC4c5ccccc5-c5ccccc54)C(=O)O)cc3)=CN1C2=O.
What is the InChIKey of [(2S)-1-[[(2S)-1-[4-[(6aS)-3-[5-[[(6aS)-2-methoxy-8-[4-(4-methylpiperazin-1-yl)phenyl]-11-oxo-6a,7-dihydropyrrolo[2,1-c][1,4]benzodiazepin-3-yl]oxy]pentoxy]-2-methoxy-11-oxo-6a,7-dihydropyrrolo[2,1-c][1,4]benzodiazepin-8-yl]anilino]-1-oxopropan-2-yl]amino]-3-methyl-1-oxobutan-2-yl]-(9H-fluoren-9-ylmethyl)carbamic acid?
The InChIKey is JGWFMPLTSGIRNV-PPZHCWCGSA-N. The full InChI is InChI=1S/C71H75N9O10/c1-43(2)66(80(71(85)86)42-59-55-16-10-8-14-53(55)54-15-9-11-17-56(54)59)68(82)74-44(3)67(81)75-49-22-18-45(19-23-49)47-32-51-38-72-60-36-64(62(87-5)34-57(60)69(83)78(51)40-47)89-30-12-7-13-31-90-65-37-61-58(35-63(65)88-6)70(84)79-41-48(33-52(79)39-73-61)46-20-24-50(25-21-46)77-28-26-76(4)27-29-77/h8-11,14-25,34-41,43-44,51-52,59,66H,7,12-13,26-33,42H2,1-6H3,(H,74,82)(H,75,81)(H,85,86)/t44-,51-,52-,66-/m0/s1.
What are the key properties of [(2S)-1-[[(2S)-1-[4-[(6aS)-3-[5-[[(6aS)-2-methoxy-8-[4-(4-methylpiperazin-1-yl)phenyl]-11-oxo-6a,7-dihydropyrrolo[2,1-c][1,4]benzodiazepin-3-yl]oxy]pentoxy]-2-methoxy-11-oxo-6a,7-dihydropyrrolo[2,1-c][1,4]benzodiazepin-8-yl]anilino]-1-oxopropan-2-yl]amino]-3-methyl-1-oxobutan-2-yl]-(9H-fluoren-9-ylmethyl)carbamic acid?
[(2S)-1-[[(2S)-1-[4-[(6aS)-3-[5-[[(6aS)-2-methoxy-8-[4-(4-methylpiperazin-1-yl)phenyl]-11-oxo-6a,7-dihydropyrrolo[2,1-c][1,4]benzodiazepin-3-yl]oxy]pentoxy]-2-methoxy-11-oxo-6a,7-dihydropyrrolo[2,1-c][1,4]benzodiazepin-8-yl]anilino]-1-oxopropan-2-yl]amino]-3-methyl-1-oxobutan-2-yl]-(9H-fluoren-9-ylmethyl)carbamic acid has a molecular weight of 1214.43 g/mol, XLogP of 11.29, 21 rotatable bonds, 3 hydrogen bond donors, and 13 hydrogen bond acceptors.
Where does this data come from?
All data for [(2S)-1-[[(2S)-1-[4-[(6aS)-3-[5-[[(6aS)-2-methoxy-8-[4-(4-methylpiperazin-1-yl)phenyl]-11-oxo-6a,7-dihydropyrrolo[2,1-c][1,4]benzodiazepin-3-yl]oxy]pentoxy]-2-methoxy-11-oxo-6a,7-dihydropyrrolo[2,1-c][1,4]benzodiazepin-8-yl]anilino]-1-oxopropan-2-yl]amino]-3-methyl-1-oxobutan-2-yl]-(9H-fluoren-9-ylmethyl)carbamic acid is sourced from PubChem (CID 122506113), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).